Skyran Biologics

Skyran Biologics is a company engaged in treating diabetic retinopathy without intraocular injections. It develops a small protein therapeutics, delivered as an eye drop, a mimetic of the active binding region of Pigment Epithelium-Derived Factor (PEDF).